Auctus Management bolts on drug company to PharmaZell
Swiss pharmaceuticals company Novartis has sold GEA Pharmaceuticals to Auctus Management, as the first step in its buy and build strategy for drug producer PharmaZell.
Swiss pharmaceuticals company Novartis has sold GEA Pharmaceuticals to Auctus Management, as the first step in its buy and build strategy for drug producer PharmaZell.
Copyright PEI Media
Not for publication, email or dissemination